🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is aPhase II Study of Leronlimab (PRO 140) in combination with Regoraf...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-09-20
Trial ID
NCT05730673
Combination of anti-angiogenic molecular targeted therapy and anti- program...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2020-12-16
Trial ID
NCT04183088
The main objective is to evaluate the impact of a Regorafenib combined with...
Status
Recruiting
Location
CHU d'Auxerre
Start Date
2024-07-19
Trial ID
NCT06425133
This study evaluates the interest of regorafenib in combination of metronom...
Status
Recruiting
Location
CHU de Besançon
Start Date
2023-05-09
Trial ID
NCT05462613
The present protocol (STRAT-aHCC trial) aims to prospectively evaluate the ...
Status
Active Not Recruiting
Location
ICESP - Instituto do Câncer do Estado de São Paulo
Start Date
2023-09-10
Trial ID
NCT05622136
Treatments Being Tested